Global Oral Ursodeoxycholic Acid Market Growth 2022-2028
Ursodeoxycholic acid, whose chemical name is 3a,7β-dihydroxy-5β-cholestane-24-acid, is an organic compound with an odorless, bitter taste. It is used in medicine to increase the secretion of bile acid, change the composition of bile, reduce cholesterol and cholesterol lipid in bile, and help the cholesterol in gallstones to gradually dissolve.
The global market for Oral Ursodeoxycholic Acid is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Ursodeoxycholic Acid market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Ursodeoxycholic Acid market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Ursodeoxycholic Acid market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Ursodeoxycholic Acid market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Ursodeoxycholic Acid players cover Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma and Mitsubishi Tanabe Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Ursodeoxycholic Acid market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Ursodeoxycholic Acid market, with both quantitative and qualitative data, to help readers understand how the Oral Ursodeoxycholic Acid market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Oral Ursodeoxycholic Acid market and forecasts the market size by Type (Tablet and Capsule,), by Application (Gallstones, Liver Disease, Stomach Trouble and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Tablet
Capsule
Segmentation by application
Gallstones
Liver Disease
Stomach Trouble
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Chapter Introduction
Chapter 1: Scope of Oral Ursodeoxycholic Acid, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Ursodeoxycholic Acid market size (sales and revenue) and CAGR, Oral Ursodeoxycholic Acid market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Ursodeoxycholic Acid sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Ursodeoxycholic Acid sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Ursodeoxycholic Acid market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini and Impax, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Ursodeoxycholic Acid Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Ursodeoxycholic Acid by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Ursodeoxycholic Acid by Country/Region, 2017, 2022 & 2028
2.2 Oral Ursodeoxycholic Acid Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Oral Ursodeoxycholic Acid Sales by Type
2.3.1 Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Ursodeoxycholic Acid Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Ursodeoxycholic Acid Sale Price by Type (2017-2022)
2.4 Oral Ursodeoxycholic Acid Segment by Application
2.4.1 Gallstones
2.4.2 Liver Disease
2.4.3 Stomach Trouble
2.4.4 Other
2.5 Oral Ursodeoxycholic Acid Sales by Application
2.5.1 Global Oral Ursodeoxycholic Acid Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Ursodeoxycholic Acid Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Ursodeoxycholic Acid Sale Price by Application (2017-2022)
3 Global Oral Ursodeoxycholic Acid by Company
3.1 Global Oral Ursodeoxycholic Acid Breakdown Data by Company
3.1.1 Global Oral Ursodeoxycholic Acid Annual Sales by Company (2020-2022)
3.1.2 Global Oral Ursodeoxycholic Acid Sales Market Share by Company (2020-2022)
3.2 Global Oral Ursodeoxycholic Acid Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Ursodeoxycholic Acid Revenue by Company (2020-2022)
3.2.2 Global Oral Ursodeoxycholic Acid Revenue Market Share by Company (2020-2022)
3.3 Global Oral Ursodeoxycholic Acid Sale Price by Company
3.4 Key Manufacturers Oral Ursodeoxycholic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Ursodeoxycholic Acid Product Location Distribution
3.4.2 Players Oral Ursodeoxycholic Acid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Ursodeoxycholic Acid by Geographic Region
4.1 World Historic Oral Ursodeoxycholic Acid Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Ursodeoxycholic Acid Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Ursodeoxycholic Acid Annual Revenue by Geographic Region
4.2 World Historic Oral Ursodeoxycholic Acid Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Ursodeoxycholic Acid Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Ursodeoxycholic Acid Annual Revenue by Country/Region
4.3 Americas Oral Ursodeoxycholic Acid Sales Growth
4.4 APAC Oral Ursodeoxycholic Acid Sales Growth
4.5 Europe Oral Ursodeoxycholic Acid Sales Growth
4.6 Middle East & Africa Oral Ursodeoxycholic Acid Sales Growth
5 Americas
5.1 Americas Oral Ursodeoxycholic Acid Sales by Country
5.1.1 Americas Oral Ursodeoxycholic Acid Sales by Country (2017-2022)
5.1.2 Americas Oral Ursodeoxycholic Acid Revenue by Country (2017-2022)
5.2 Americas Oral Ursodeoxycholic Acid Sales by Type
5.3 Americas Oral Ursodeoxycholic Acid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Ursodeoxycholic Acid Sales by Region
6.1.1 APAC Oral Ursodeoxycholic Acid Sales by Region (2017-2022)
6.1.2 APAC Oral Ursodeoxycholic Acid Revenue by Region (2017-2022)
6.2 APAC Oral Ursodeoxycholic Acid Sales by Type
6.3 APAC Oral Ursodeoxycholic Acid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Ursodeoxycholic Acid by Country
7.1.1 Europe Oral Ursodeoxycholic Acid Sales by Country (2017-2022)
7.1.2 Europe Oral Ursodeoxycholic Acid Revenue by Country (2017-2022)
7.2 Europe Oral Ursodeoxycholic Acid Sales by Type
7.3 Europe Oral Ursodeoxycholic Acid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Ursodeoxycholic Acid by Country
8.1.1 Middle East & Africa Oral Ursodeoxycholic Acid Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Ursodeoxycholic Acid Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Ursodeoxycholic Acid Sales by Type
8.3 Middle East & Africa Oral Ursodeoxycholic Acid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Ursodeoxycholic Acid
10.3 Manufacturing Process Analysis of Oral Ursodeoxycholic Acid
10.4 Industry Chain Structure of Oral Ursodeoxycholic Acid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Ursodeoxycholic Acid Distributors
11.3 Oral Ursodeoxycholic Acid Customer
12 World Forecast Review for Oral Ursodeoxycholic Acid by Geographic Region
12.1 Global Oral Ursodeoxycholic Acid Market Size Forecast by Region
12.1.1 Global Oral Ursodeoxycholic Acid Forecast by Region (2023-2028)
12.1.2 Global Oral Ursodeoxycholic Acid Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Ursodeoxycholic Acid Forecast by Type
12.7 Global Oral Ursodeoxycholic Acid Forecast by Application
13 Key Players Analysis
13.1 Dr. Falk Pharma
13.1.1 Dr. Falk Pharma Company Information
13.1.2 Dr. Falk Pharma Oral Ursodeoxycholic Acid Product Offered
13.1.3 Dr. Falk Pharma Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Dr. Falk Pharma Main Business Overview
13.1.5 Dr. Falk Pharma Latest Developments
13.2 Daewoong Pharmaceutical
13.2.1 Daewoong Pharmaceutical Company Information
13.2.2 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Product Offered
13.2.3 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Daewoong Pharmaceutical Main Business Overview
13.2.5 Daewoong Pharmaceutical Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Oral Ursodeoxycholic Acid Product Offered
13.3.3 Teva Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Epic Pharma
13.4.1 Epic Pharma Company Information
13.4.2 Epic Pharma Oral Ursodeoxycholic Acid Product Offered
13.4.3 Epic Pharma Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Epic Pharma Main Business Overview
13.4.5 Epic Pharma Latest Developments
13.5 Mitsubishi Tanabe Pharma
13.5.1 Mitsubishi Tanabe Pharma Company Information
13.5.2 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Product Offered
13.5.3 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mitsubishi Tanabe Pharma Main Business Overview
13.5.5 Mitsubishi Tanabe Pharma Latest Developments
13.6 Lannett
13.6.1 Lannett Company Information
13.6.2 Lannett Oral Ursodeoxycholic Acid Product Offered
13.6.3 Lannett Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lannett Main Business Overview
13.6.5 Lannett Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Oral Ursodeoxycholic Acid Product Offered
13.7.3 Mylan Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Bruschettini
13.8.1 Bruschettini Company Information
13.8.2 Bruschettini Oral Ursodeoxycholic Acid Product Offered
13.8.3 Bruschettini Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bruschettini Main Business Overview
13.8.5 Bruschettini Latest Developments
13.9 Impax
13.9.1 Impax Company Information
13.9.2 Impax Oral Ursodeoxycholic Acid Product Offered
13.9.3 Impax Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Impax Main Business Overview
13.9.5 Impax Latest Developments
13.10 Shanghai Pharma
13.10.1 Shanghai Pharma Company Information
13.10.2 Shanghai Pharma Oral Ursodeoxycholic Acid Product Offered
13.10.3 Shanghai Pharma Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shanghai Pharma Main Business Overview
13.10.5 Shanghai Pharma Latest Developments
13.11 Grindeks
13.11.1 Grindeks Company Information
13.11.2 Grindeks Oral Ursodeoxycholic Acid Product Offered
13.11.3 Grindeks Oral Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Grindeks Main Business Overview
13.11.5 Grindeks Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Oral Ursodeoxycholic Acid Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Ursodeoxycholic Acid Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Global Oral Ursodeoxycholic Acid Sales by Type (2017-2022) & (K Units)
Table 6. Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
Table 7. Global Oral Ursodeoxycholic Acid Revenue by Type (2017-2022) & ($ million)
Table 8. Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2017-2022)
Table 9. Global Oral Ursodeoxycholic Acid Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Oral Ursodeoxycholic Acid Sales by Application (2017-2022) & (K Units)
Table 11. Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Table 12. Global Oral Ursodeoxycholic Acid Revenue by Application (2017-2022)
Table 13. Global Oral Ursodeoxycholic Acid Revenue Market Share by Application (2017-2022)
Table 14. Global Oral Ursodeoxycholic Acid Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Oral Ursodeoxycholic Acid Sales by Company (2020-2022) & (K Units)
Table 16. Global Oral Ursodeoxycholic Acid Sales Market Share by Company (2020-2022)
Table 17. Global Oral Ursodeoxycholic Acid Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oral Ursodeoxycholic Acid Revenue Market Share by Company (2020-2022)
Table 19. Global Oral Ursodeoxycholic Acid Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Oral Ursodeoxycholic Acid Producing Area Distribution and Sales Area
Table 21. Players Oral Ursodeoxycholic Acid Products Offered
Table 22. Oral Ursodeoxycholic Acid Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Ursodeoxycholic Acid Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Oral Ursodeoxycholic Acid Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oral Ursodeoxycholic Acid Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oral Ursodeoxycholic Acid Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oral Ursodeoxycholic Acid Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Oral Ursodeoxycholic Acid Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oral Ursodeoxycholic Acid Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oral Ursodeoxycholic Acid Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oral Ursodeoxycholic Acid Sales by Country (2017-2022) & (K Units)
Table 34. Americas Oral Ursodeoxycholic Acid Sales Market Share by Country (2017-2022)
Table 35. Americas Oral Ursodeoxycholic Acid Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oral Ursodeoxycholic Acid Revenue Market Share by Country (2017-2022)
Table 37. Americas Oral Ursodeoxycholic Acid Sales by Type (2017-2022) & (K Units)
Table 38. Americas Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
Table 39. Americas Oral Ursodeoxycholic Acid Sales by Application (2017-2022) & (K Units)
Table 40. Americas Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Table 41. APAC Oral Ursodeoxycholic Acid Sales by Region (2017-2022) & (K Units)
Table 42. APAC Oral Ursodeoxycholic Acid Sales Market Share by Region (2017-2022)
Table 43. APAC Oral Ursodeoxycholic Acid Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oral Ursodeoxycholic Acid Revenue Market Share by Region (2017-2022)
Table 45. APAC Oral Ursodeoxycholic Acid Sales by Type (2017-2022) & (K Units)
Table 46. APAC Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
Table 47. APAC Oral Ursodeoxycholic Acid Sales by Application (2017-2022) & (K Units)
Table 48. APAC Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Table 49. Europe Oral Ursodeoxycholic Acid Sales by Country (2017-2022) & (K Units)
Table 50. Europe Oral Ursodeoxycholic Acid Sales Market Share by Country (2017-2022)
Table 51. Europe Oral Ursodeoxycholic Acid Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oral Ursodeoxycholic Acid Revenue Market Share by Country (2017-2022)
Table 53. Europe Oral Ursodeoxycholic Acid Sales by Type (2017-2022) & (K Units)
Table 54. Europe Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
Table 55. Europe Oral Ursodeoxycholic Acid Sales by Application (2017-2022) & (K Units)
Table 56. Europe Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oral Ursodeoxycholic Acid Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Oral Ursodeoxycholic Acid Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oral Ursodeoxycholic Acid Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oral Ursodeoxycholic Acid Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Ursodeoxycholic Acid Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Oral Ursodeoxycholic Acid Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Oral Ursodeoxycholic Acid Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oral Ursodeoxycholic Acid
Table 66. Key Market Challenges & Risks of Oral Ursodeoxycholic Acid
Table 67. Key Industry Trends of Oral Ursodeoxycholic Acid
Table 68. Oral Ursodeoxycholic Acid Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oral Ursodeoxycholic Acid Distributors List
Table 71. Oral Ursodeoxycholic Acid Customer List
Table 72. Global Oral Ursodeoxycholic Acid Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Oral Ursodeoxycholic Acid Sales Market Forecast by Region
Table 74. Global Oral Ursodeoxycholic Acid Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oral Ursodeoxycholic Acid Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oral Ursodeoxycholic Acid Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Oral Ursodeoxycholic Acid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oral Ursodeoxycholic Acid Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Oral Ursodeoxycholic Acid Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oral Ursodeoxycholic Acid Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Oral Ursodeoxycholic Acid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oral Ursodeoxycholic Acid Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Oral Ursodeoxycholic Acid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oral Ursodeoxycholic Acid Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Oral Ursodeoxycholic Acid Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Ursodeoxycholic Acid Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Oral Ursodeoxycholic Acid Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Ursodeoxycholic Acid Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Oral Ursodeoxycholic Acid Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Ursodeoxycholic Acid Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oral Ursodeoxycholic Acid Revenue Market Share Forecast by Application (2023-2028)
Table 92. Dr. Falk Pharma Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 93. Dr. Falk Pharma Oral Ursodeoxycholic Acid Product Offered
Table 94. Dr. Falk Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Dr. Falk Pharma Main Business
Table 96. Dr. Falk Pharma Latest Developments
Table 97. Daewoong Pharmaceutical Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 98. Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Product Offered
Table 99. Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Daewoong Pharmaceutical Main Business
Table 101. Daewoong Pharmaceutical Latest Developments
Table 102. Teva Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Oral Ursodeoxycholic Acid Product Offered
Table 104. Teva Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Epic Pharma Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 108. Epic Pharma Oral Ursodeoxycholic Acid Product Offered
Table 109. Epic Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Epic Pharma Main Business
Table 111. Epic Pharma Latest Developments
Table 112. Mitsubishi Tanabe Pharma Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 113. Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Product Offered
Table 114. Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Mitsubishi Tanabe Pharma Main Business
Table 116. Mitsubishi Tanabe Pharma Latest Developments
Table 117. Lannett Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 118. Lannett Oral Ursodeoxycholic Acid Product Offered
Table 119. Lannett Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Lannett Main Business
Table 121. Lannett Latest Developments
Table 122. Mylan Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan Oral Ursodeoxycholic Acid Product Offered
Table 124. Mylan Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Bruschettini Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 128. Bruschettini Oral Ursodeoxycholic Acid Product Offered
Table 129. Bruschettini Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bruschettini Main Business
Table 131. Bruschettini Latest Developments
Table 132. Impax Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 133. Impax Oral Ursodeoxycholic Acid Product Offered
Table 134. Impax Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Impax Main Business
Table 136. Impax Latest Developments
Table 137. Shanghai Pharma Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 138. Shanghai Pharma Oral Ursodeoxycholic Acid Product Offered
Table 139. Shanghai Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Shanghai Pharma Main Business
Table 141. Shanghai Pharma Latest Developments
Table 142. Grindeks Basic Information, Oral Ursodeoxycholic Acid Manufacturing Base, Sales Area and Its Competitors
Table 143. Grindeks Oral Ursodeoxycholic Acid Product Offered
Table 144. Grindeks Oral Ursodeoxycholic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Grindeks Main Business
Table 146. Grindeks Latest Developments
List of Figures
Figure 1. Picture of Oral Ursodeoxycholic Acid
Figure 2. Oral Ursodeoxycholic Acid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Ursodeoxycholic Acid Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Ursodeoxycholic Acid Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Ursodeoxycholic Acid Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsule
Figure 11. Global Oral Ursodeoxycholic Acid Sales Market Share by Type in 2021
Figure 12. Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2017-2022)
Figure 13. Oral Ursodeoxycholic Acid Consumed in Gallstones
Figure 14. Global Oral Ursodeoxycholic Acid Market: Gallstones (2017-2022) & (K Units)
Figure 15. Oral Ursodeoxycholic Acid Consumed in Liver Disease
Figure 16. Global Oral Ursodeoxycholic Acid Market: Liver Disease (2017-2022) & (K Units)
Figure 17. Oral Ursodeoxycholic Acid Consumed in Stomach Trouble
Figure 18. Global Oral Ursodeoxycholic Acid Market: Stomach Trouble (2017-2022) & (K Units)
Figure 19. Oral Ursodeoxycholic Acid Consumed in Other
Figure 20. Global Oral Ursodeoxycholic Acid Market: Other (2017-2022) & (K Units)
Figure 21. Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2017-2022)
Figure 22. Global Oral Ursodeoxycholic Acid Revenue Market Share by Application in 2021
Figure 23. Oral Ursodeoxycholic Acid Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Oral Ursodeoxycholic Acid Revenue Market Share by Company in 2021
Figure 25. Global Oral Ursodeoxycholic Acid Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Oral Ursodeoxycholic Acid Revenue Market Share by Geographic Region in 2021
Figure 27. Global Oral Ursodeoxycholic Acid Sales Market Share by Region (2017-2022)
Figure 28. Global Oral Ursodeoxycholic Acid Revenue Market Share by Country/Region in 2021
Figure 29. Americas Oral Ursodeoxycholic Acid Sales 2017-2022 (K Units)
Figure 30. Americas Oral Ursodeoxycholic Acid Revenue 2017-2022 ($ Millions)
Figure 31. APAC Oral Ursodeoxycholic Acid Sales 2017-2022 (K Units)
Figure 32. APAC Oral Ursodeoxycholic Acid Revenue 2017-2022 ($ Millions)
Figure 33. Europe Oral Ursodeoxycholic Acid Sales 2017-2022 (K Units)
Figure 34. Europe Oral Ursodeoxycholic Acid Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Oral Ursodeoxycholic Acid Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Oral Ursodeoxycholic Acid Revenue 2017-2022 ($ Millions)
Figure 37. Americas Oral Ursodeoxycholic Acid Sales Market Share by Country in 2021
Figure 38. Americas Oral Ursodeoxycholic Acid Revenue Market Share by Country in 2021
Figure 39. United States Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Oral Ursodeoxycholic Acid Sales Market Share by Region in 2021
Figure 44. APAC Oral Ursodeoxycholic Acid Revenue Market Share by Regions in 2021
Figure 45. China Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Oral Ursodeoxycholic Acid Sales Market Share by Country in 2021
Figure 52. Europe Oral Ursodeoxycholic Acid Revenue Market Share by Country in 2021
Figure 53. Germany Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Oral Ursodeoxycholic Acid Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Oral Ursodeoxycholic Acid Revenue Market Share by Country in 2021
Figure 60. Egypt Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Oral Ursodeoxycholic Acid Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Oral Ursodeoxycholic Acid in 2021
Figure 66. Manufacturing Process Analysis of Oral Ursodeoxycholic Acid
Figure 67. Industry Chain Structure of Oral Ursodeoxycholic Acid
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets